• Trade
  • Markets
  • Copy
  • Contests
  • News
  • 24/7
  • Calendar
  • Q&A
  • Chats
Trending
Screeners
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6827.42
6827.42
6827.42
6899.86
6801.80
-73.58
-1.07%
--
DJI
Dow Jones Industrial Average
48458.04
48458.04
48458.04
48886.86
48334.10
-245.98
-0.51%
--
IXIC
NASDAQ Composite Index
23195.16
23195.16
23195.16
23554.89
23094.51
-398.69
-1.69%
--
USDX
US Dollar Index
97.920
98.000
97.920
98.070
97.890
-0.030
-0.03%
--
EURUSD
Euro / US Dollar
1.17429
1.17437
1.17429
1.17465
1.17262
+0.00035
+ 0.03%
--
GBPUSD
Pound Sterling / US Dollar
1.33782
1.33791
1.33782
1.33882
1.33546
+0.00075
+ 0.06%
--
XAUUSD
Gold / US Dollar
4340.06
4340.47
4340.06
4350.16
4294.68
+40.67
+ 0.95%
--
WTI
Light Sweet Crude Oil
57.129
57.159
57.129
57.601
57.107
-0.104
-0.18%
--

Community Accounts

Signal Accounts
--
Profit Accounts
--
Loss Accounts
--
View More

Become a signal provider

Sell trading signals to earn additional income

View More

Guide to Copy Trading

Get started with ease and confidence

View More

Signal Accounts for Members

All Signal Accounts

Best Return
  • Best Return
  • Best P/L
  • Best MDD
Past 1W
  • Past 1W
  • Past 1M
  • Past 1Y

All Contests

  • All
  • Trump Updates
  • Recommend
  • Stocks
  • Cryptocurrencies
  • Central Banks
  • Featured News
Top News Only
Share

EU Official: EU Foreign Ministers Adopt Sanctions Targeting 14 Persons, Entities Under Russia Hybrid Threats Regime

Share

Polish Zloty Firms To 4.2175 Versus Euro, Strongest Since Early April

Share

China Npc Standing Committee Meeting To Review Draft Revision To Foreign Trade Law

Share

China Npc Standing Committee To Hold Meeting Dec 22-27

Share

The European Council Stated That, In Light Of Recent Mixed Activities And Threats Against Member States, It Has Expanded The List Of Individuals And Entities That Support Or Benefit From Actions Linked To The Belarusian Government

Share

Croatian Consumer Prices Up 3.8% Year-On-Year In November

Share

U.S. Government Documents Show That The U.S. Demanded That The EU Commit To Not Imposing Penalties If The U.S. Oil And Gas Industry Violated Methane Regulations

Share

U.S. Government Documents Show That The U.S. Is Demanding That The EU Exempt U.S. Natural Gas From Its Obligations Under The Methane Law By 2035

Share

Iranian Foreign Ministry: Iranian Foreign Minister Meets With Belarusian Foreign Minister In Minsk

Share

Russia's Nornickel Sees Global Palladium Market Balanced In 2025, Sees Deficit At 0.2 Moz Including Investments

Share

Russia's Nornickel Sees 2026 Global Palladium Market Deficit At 0.1 Moz Excluding Investments

Share

European Central Bank: Total Value Of Fraud Increased To €4.2 Billion In 2024 From €3.5 Billion In 2023

Share

Indian Rupee Ends At Record Closing Low Of 90.7250 Per USA Dollar, Down 0.3% On Day

Share

Romania's Current Account Deficit Widens To 24.64 Billion Euros In Jan-Oct Versus Revised Deficit Of 23.64 Billion Euros In Jan-Oct Year Ago - Central Bank Data

Share

According To A Fox News Reporter, The U.S. Senate Will Hold A Procedural Vote On The Annual Defense Bill Today

Share

India's Nov Gold Imports At $4.02 Billion

Share

India's Nov Oil Imports At $ 14.12 Billion

Share

Kremlin: Ukraine Not Joining NATO Is One Of The Key Questions, But Subject To Special Discussion

Share

Kremlin: After Talks In Berlin Between USA, Europeans And Ukraine, We Expect The USA To Update Moscow On Proposals

Share

EU Official: Witkoff And Kushner Begin Briefing EU Foreign Ministers On Gaza Via Videoconference

TIME
ACT
FCST
PREV
China, Mainland M0 Money Supply YoY (Nov)

A:--

F: --

P: --

China, Mainland M1 Money Supply YoY (Nov)

A:--

F: --

P: --

India CPI YoY (Nov)

A:--

F: --

P: --

India Deposit Gowth YoY

A:--

F: --

P: --

Brazil Services Growth YoY (Oct)

A:--

F: --

P: --

Mexico Industrial Output YoY (Oct)

A:--

F: --

P: --

Russia Trade Balance (Oct)

A:--

F: --

P: --

Philadelphia Fed President Henry Paulson delivers a speech
Canada Building Permits MoM (SA) (Oct)

A:--

F: --

P: --

Canada Wholesale Sales YoY (Oct)

A:--

F: --

P: --

Canada Wholesale Inventory MoM (Oct)

A:--

F: --

P: --

Canada Wholesale Inventory YoY (Oct)

A:--

F: --

P: --

Canada Wholesale Sales MoM (SA) (Oct)

A:--

F: --

P: --

Germany Current Account (Not SA) (Oct)

A:--

F: --

P: --

U.S. Weekly Total Rig Count

A:--

F: --

P: --

U.S. Weekly Total Oil Rig Count

A:--

F: --

P: --

Japan Tankan Small Manufacturing Outlook Index (Q4)

A:--

F: --

P: --

Japan Tankan Large Non-Manufacturing Diffusion Index (Q4)

A:--

F: --

P: --

Japan Tankan Large Non-Manufacturing Outlook Index (Q4)

A:--

F: --

P: --

Japan Tankan Large Manufacturing Outlook Index (Q4)

A:--

F: --

P: --

Japan Tankan Small Manufacturing Diffusion Index (Q4)

A:--

F: --

P: --

Japan Tankan Large Manufacturing Diffusion Index (Q4)

A:--

F: --

P: --

Japan Tankan Large-Enterprise Capital Expenditure YoY (Q4)

A:--

F: --

P: --

U.K. Rightmove House Price Index YoY (Dec)

A:--

F: --

P: --

China, Mainland Industrial Output YoY (YTD) (Nov)

A:--

F: --

P: --

China, Mainland Urban Area Unemployment Rate (Nov)

A:--

F: --

P: --

Saudi Arabia CPI YoY (Nov)

A:--

F: --

P: --

Euro Zone Industrial Output YoY (Oct)

A:--

F: --

P: --

Euro Zone Industrial Output MoM (Oct)

A:--

F: --

P: --

Canada Existing Home Sales MoM (Nov)

A:--

F: --

P: --

Euro Zone Total Reserve Assets (Nov)

--

F: --

P: --

U.K. Inflation Rate Expectations

--

F: --

P: --

Canada National Economic Confidence Index

--

F: --

P: --

Canada New Housing Starts (Nov)

--

F: --

P: --

U.S. NY Fed Manufacturing Employment Index (Dec)

--

F: --

P: --

U.S. NY Fed Manufacturing Index (Dec)

--

F: --

P: --

Canada Core CPI YoY (Nov)

--

F: --

P: --

Canada Manufacturing Unfilled Orders MoM (Oct)

--

F: --

P: --

U.S. NY Fed Manufacturing Prices Received Index (Dec)

--

F: --

P: --

U.S. NY Fed Manufacturing New Orders Index (Dec)

--

F: --

P: --

Canada Manufacturing New Orders MoM (Oct)

--

F: --

P: --

Canada Core CPI MoM (Nov)

--

F: --

P: --

Canada Trimmed CPI YoY (SA) (Nov)

--

F: --

P: --

Canada Manufacturing Inventory MoM (Oct)

--

F: --

P: --

Canada CPI YoY (Nov)

--

F: --

P: --

Canada CPI MoM (Nov)

--

F: --

P: --

Canada CPI YoY (SA) (Nov)

--

F: --

P: --

Canada Core CPI MoM (SA) (Nov)

--

F: --

P: --

Canada CPI MoM (SA) (Nov)

--

F: --

P: --

Federal Reserve Board Governor Milan delivered a speech
U.S. NAHB Housing Market Index (Dec)

--

F: --

P: --

Australia Composite PMI Prelim (Dec)

--

F: --

P: --

Australia Services PMI Prelim (Dec)

--

F: --

P: --

Australia Manufacturing PMI Prelim (Dec)

--

F: --

P: --

Japan Manufacturing PMI Prelim (SA) (Dec)

--

F: --

P: --

U.K. 3-Month ILO Employment Change (Oct)

--

F: --

P: --

U.K. Unemployment Claimant Count (Nov)

--

F: --

P: --

U.K. Unemployment Rate (Nov)

--

F: --

P: --

U.K. 3-Month ILO Unemployment Rate (Oct)

--

F: --

P: --

U.K. Average Weekly Earnings (3-Month Average, Including Bonuses) YoY (Oct)

--

F: --

P: --

U.K. Average Weekly Earnings (3-Month Average, Excluding Bonuses) YoY (Oct)

--

F: --

P: --

Q&A with Experts
    • All
    • Chatrooms
    • Groups
    • Friends
    Connecting
    .
    .
    .
    Type here...
    Add Symbol or Code

      No matching data

      All
      Trump Updates
      Recommend
      Stocks
      Cryptocurrencies
      Central Banks
      Featured News
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      Search
      Products

      Charts Free Forever

      Chats Q&A with Experts
      Screeners Economic Calendar Data Tools
      Membership Features
      Data Warehouse Market Trends Institutional Data Policy Rates Macro

      Market Trends

      Market Sentiment Order Book Forex Correlations

      Top Indicators

      Charts Free Forever
      Markets

      News

      News Analysis 24/7 Columns Education
      From Institutions From Analysts
      Topics Columnists

      Latest Views

      Latest Views

      Trending Topics

      Top Columnists

      Latest Update

      Signals

      Copy Rankings Latest Signals Become a signal provider AI Rating
      Contests
      Brokers

      Overview Brokers Assessment Rankings Regulators News Claims
      Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
      Q&A Complaint Scam Alert Videos Tips to Detect Scam
      More

      Business
      Events
      Careers About Us Advertising Help Center

      White Label

      Data API

      Web Plug-ins

      Affiliate Program

      Awards Institution Evaluation IB Seminar Salon Event Exhibition
      Vietnam Thailand Singapore Dubai
      Fans Party Investment Sharing Session
      FastBull Summit BrokersView Expo
      Recent Searches
        Top Searches
          Markets
          News
          Analysis
          User
          24/7
          Economic Calendar
          Education
          Data
          • Names
          • Latest
          • Prev

          View All

          No data

          Scan to Download

          Faster Charts, Chat Faster!

          Download App
          English
          • English
          • Español
          • العربية
          • Bahasa Indonesia
          • Bahasa Melayu
          • Tiếng Việt
          • ภาษาไทย
          • Français
          • Italiano
          • Türkçe
          • Русский язык
          • 简中
          • 繁中
          Open Account
          Search
          Products
          Charts Free Forever
          Markets
          News
          Signals

          Copy Rankings Latest Signals Become a signal provider AI Rating
          Contests
          Brokers

          Overview Brokers Assessment Rankings Regulators News Claims
          Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
          Q&A Complaint Scam Alert Videos Tips to Detect Scam
          More

          Business
          Events
          Careers About Us Advertising Help Center

          White Label

          Data API

          Web Plug-ins

          Affiliate Program

          Awards Institution Evaluation IB Seminar Salon Event Exhibition
          Vietnam Thailand Singapore Dubai
          Fans Party Investment Sharing Session
          FastBull Summit BrokersView Expo

          Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims

          Benzinga
          Abbott Laboratories
          +1.77%
          D.R. Horton
          +0.81%
          American Express
          -0.61%
          Schlumberger
          -2.21%
          Halliburton
          -1.72%

          The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the “Neutral” zone on Thursday.

          U.S. stocks closed lower on Thursday, with the Dow Jones index falling more than 500 points during the session.

          On the economic data front, U.S. initial jobless claims increased by 10,000 to 243,000 in the week ending July 13, compared to market estimates of 230,000. The Philadelphia Fed Manufacturing Index rose to 13.9 in July, recording the strongest level in three months, versus 1.3 in June.

          Abbott Laboratories reported better-than-expected earnings for its second quarter on Thursday. D.R. Horton, Inc. reported stronger-than-expected second-quarter earnings.

          Most sectors on the S&P 500 closed on a negative note, with healthcare, consumer discretionary and financials stocks recording the biggest losses on Thursday. However, energy stocks bucked the overall market trend, closing the session higher.

          The Dow Jones closed lower by around 533 points to 40,665.02 on Thursday. The S&P 500 fell 0.78% at 5,544.59, while the Nasdaq Composite dipped 0.70% at 17,871.22 during Thursday's session.

          Investors are awaiting earnings results from American Express Company , Schlumberger Limited and Halliburton Company today.

          What is CNN Business Fear & Greed Index?

          At a current reading of 50.6, the index moved to the “Neutral” zone on Thursday, versus a prior reading of 59.

          The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.

          Read Next:

          • Top 3 Tech Stocks You May Want To Dump This Quarter

          Stocks Photo by Phongphan on Shutterstock

          © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Sector Update: Health Care Stocks Fall in Late Afternoon Trading

          MT Newswires
          Cassava Sciences
          -6.98%
          Silo Pharma
          -2.47%
          Abbott Laboratories
          +1.77%
          Agenus
          -7.11%

          Health care stocks were retreating late Thursday afternoon, with the NYSE Health Care Index falling 2.5% and the Health Care Select Sector SPDR Fund (XLV) dropping 2.3%.

          The iShares Biotechnology ETF (IBB) shed 1.7%.

          In corporate news, Cassava Sciences shares jumped 5.1% after the Delaware Court of Chancery scheduled a hearing to dismiss a lawsuit against the company's officers.

          Silo Pharma shares surged 57% as it said Thursday it entered into a device and development master plan with medical technology provider Resyca.

          Abbott Laboratories reported bigger-than-expected increases in Q2 results amid revenue growth in medical device and nutrition, and the company raised its full-year earnings forecast. The shares fell 4.5%.

          Agenus shares plunged nearly 59% after the US Food and Drug Administration advised against an accelerated approval pathway for the company's potential colorectal cancer combination treatment.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Nyse Order Imbalance 338209.0 Shares On Sell Side

          Reuters
          Abbott Laboratories
          +1.77%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Abbott CEO Warns of Health Crisis if Preterm Formula Pulled — Market Talk

          Dow Jones Newswires
          Abbott Laboratories
          +1.77%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views

          Benzinga
          Abbott Laboratories
          +1.77%
          CommScope
          -5.40%
          Silo Pharma
          -2.47%
          Chuy's Holdings
          0.00%
          Agenus
          -7.11%

          U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Thursday.

          The Dow traded down 1.08% to 40,752.05 while the NASDAQ fell 0.80% to 17,853.34. The S&P 500 also fell, dropping, 0.75% to 5,546.48.

          Check This Out: Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July

          Leading and Lagging Sectors

          Energy shares jumped by 1.1% on Thursday.

          In trading on Thursday, health care shares fell by 1.6%.

          Top Headline

          Abbott Laboratories reported better-than-expected earnings for its second quarter on Thursday.

          The company posted sales of $10.38 billion, up 4%, almost in line with the consensus of $10.37 billion. Abbott's adjusted diluted earnings per share was $1.14, beating the analyst estimates of $1.10.

          Abbott said it projects full-year 2024 GAAP EPS of $3.30-$3.40 versus prior guidance of $3.25-$3.40, primarily related to intangible amortization, restructuring and cost reduction initiatives and other net expenses. The company forecasts adjusted EPS of $4.61-$4.71 versus the prior guidance of $4.55-$4.70 and consensus of $4.63.

          Equities Trading UP

          • CommScope Holding Company, Inc. shares shot up 9% to $1.87. Amphenol announced plans to acquire mobile networks businesses from CommScope.
          • Shares of Silo Pharma, Inc. got a boost, surging 60% to $3.60. Silo Pharma said it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider.
          • Chuy’s Holdings, Inc. shares were also up, gaining 48% to $37.33 after Darden Restaurants announced it will acquire the company.

          Equities Trading DOWN

          • Agenus Inc. shares dropped 56% to $7.85 after the company announced the FDA discouraged an accelerated approval pathway at the end-of-Phase 2 meeting.
          • Shares of Leslie’s, Inc. were down 32% to $2.7850 after the company reported preliminary financial results for the third quarter and cut its full-year guidance. Multiple analysts also lowered price targets on the stock Thursday morning.
          • Torrid Holdings Inc. was down, falling 16% to $7.24 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and maintained its $5 price target.

          Also Check This Out: Nvidia, Electronic Arts And 2 Other Stocks Insiders Are Selling

          Commodities

          In commodity news, oil traded up 0.5% to $83.23 while gold traded down 0.1% at $2,458.60.

          Silver traded down 0.5% to $30.225 on Thursday, while copper fell 2.9% to $4.2815.

          Euro zone

          European shares closed mixed today. The eurozone's STOXX 600 fell 0.16%, Germany's DAX fell 0.45% and France's CAC 40 rose 0.21%. Spain's IBEX 35 Index rose 0.38%, while London's FTSE 100 rose 0.21%.

          Construction output in the Eurozone fell 2.4% year-over-year in May compared to a revised 1.5% decline in the prior month. Passenger car registrations in the European Union climbed 4.3% year-over-year to 1.1 million units in June.

          Regular pay in the U.K., excluding bonus payment, rose 5.7% year-over-year to GBP 643/week during the three months to May, while the unemployment rate came in unchanged at 4.4% from March to May.

          Asia Pacific Markets

          Asian markets closed mixed on Thursday, with Japan's Nikkei 225 dipping 2.36%, Hong Kong's Hang Seng Index gaining 0.22%, China's Shanghai Composite Index gaining 0.48% and India's S&P BSE Sensex climbing 0.78%.

          Hong Kong’s unemployment rate came in unchanged at 3% during the three months ending June. Japan reported a trade surplus of JPY 224.04 billion in June, compared to market views for a deficit of JPY 240 billion.

          Economics

          • U.S. initial jobless claims increased by 10,000 to 243,000 in the week ending July 13, compared to market estimates of 230,000.
          • The Philadelphia Fed Manufacturing Index rose to 13.9 in July, recording the strongest level in three months, versus 1.3 in June.
          • The EIA said U.S. natural gas stocks rose by 10 billion cubic feet in the week ended July 12, compared to market estimates of a 28 billion cubic feet gain.

          Now Read This:

          • How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings

          © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?

          Benzinga
          Abbott Laboratories
          +1.77%
          NVIDIA
          -3.27%
          Eli Lilly and Co.
          +1.80%
          Novo-Nordisk A/S
          -0.22%
          Pfizer
          +0.19%

          It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market’s fear gauge, spiked over 10%, reaching levels last seen in late April.

          Both the S&P 500 and the Nasdaq 100 indices declined by 0.6%, while the Dow Jones Industrial Average fell 0.7%, potentially ending a streak of six consecutive positive sessions.

          Small-cap stocks also succumbed to the broader negative sentiment, with the Russell 2000 index dropping 0.7%.

          Chicago Fed President Austan Goolsbee, a known “dove” on the board, expressed optimism about progress on inflation and the U.S. economy’s resilience in avoiding a recession. He did not commit to a potential rate cut in September.

          Following Wednesday’s sell-off triggered by concerns over increased U.S. chip export restrictions to China, semiconductor stocks remained broadly weaker, with the iShares Semiconductor ETF down by 0.6%. Despite this, Nvidia Corp. defied the trend, rising 1.8%.

          Significant volatility erupted in the health care sector, particularly within the weight loss drug industry. The market duopoly of Eli Lilly and Company and Novo Nordisk A/S face heightened competitive threats from Pfizer Inc. and Roche Holding Ltd , both of which recently announced developments to enter this lucrative market.

          Shares of Eli Lilly plunged 5.6%, marking their worst session since mid-March 2021, while Novo Nordisk shares dropped 5%, their worst performance since August 2022.

          On the economic data front, jobless claims rose more than expected last week and continuing claims reached their highest level since November 2021, indicating a cooling trend in the labor market.

          The U.S. dollar acted as a safe haven, rising 0.3%, while Treasury yields inched higher across the curve. The European Central Bank kept interest rates unchanged, as expected, keeping the door open for September.

          In commodities, growth-sensitive copper tumbled over 3%, hitting its lowest level since mid-April. Silver eased by 0.9% and gold remained flat. Oil prices slipped 0.3%, while natural gas surged over 4%, nearly recouping Wednesday’s sharp losses following a weaker-than-expected buildup in inventories last week.

          Bitcoin edged 0.4% lower, eyeing a second consecutive negative close.

          Thursday’s Performance In Major US Indices, ETFs

          Major IndicesPrice1-day %chg
          Nasdaq 10019,687.70-0.6%
          S&P 5005,556.41-0.6%
          Dow Jones40,929.46-0.7%
          Russell 20002,220.63-0.7%

          According to Benzinga pro data:

          • The SPDR S&P 500 ETF Trust  was 0.6% lower to $553.74.
          • The SPDR Dow Jones Industrial Average  fell by 0.7% to $409.10.
          • The tech-heavy Invesco QQQ Trust  fell 0.5% to $479.14.
          • Sector-wise, the Energy Select Sector SPDR Fund  outperformed, up by 1%, while the Health Care Select Sector SPDR Fund  lagged, down 1.5%.

          Thursday’s Market Movers

          • Taiwan Semiconductor Manufacturing Company Ltd. fell 0.9% despite reporting stronger-than-expected results last quarter.
          • Other stocks reacting to corporate earnings were Abbott Laboratories , down 3.5%, Alcoa Corporation , down 1%, SL Green Realty Corp. down 2.5%, Kinder Morgan, Inc. , up 3.8%, Domino’s Pizza, Inc. , down 13%, Blackstone Inc. , up 2.6%, Marsh & McLennan Companies, Inc. , down 1%, Alaska Air Group, Inc. , down over 5%, Cintas Corp. , up over 6%, D.R. Horton, Inc. , up 13%, Virtu Financial Inc. , up 18% and Novartis AG , down 4.4%.
          • Companies reporting after the close include Netflix, Inc. and Intuitive Surgical, Inc. .

          Read now:

          • Project 2025 Wants To Radically Change US Tax Policy: Would You Pay More Or Less In Taxes?

          Photo via Shutterstock.

          © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Abbott Plans Marketing Push For Glucose Monitors Beyond Diabetes

          Reuters
          Abbott Laboratories
          +1.77%
          DexCom
          -2.87%
          Medtronic
          +0.12%
          2024-07-19 01:37:35

          By Leroy Leo and Puyaan Singh

          July 18 (Reuters) - Abbott Laboratories ABT.N will use a mix of TV advertisements and guerilla marketing as well as seek to personalize health data to tap people without diabetes for the U.S. launch of its glucose monitoring device, CEO Robert Ford said on Thursday.

          The company plans to launch the over-the-counter device, Lingo, this year. It could be a multi-billion-dollar product for Abbott, Ford estimated, adding it was still in its early days.

          Lingo and Libre Rio, another of Abbott's devices, received clearance from the U.S. Food and Drug Administration's last month.

          Lingo targets consumers who want to better understand their health, while Libre Rio is for adults with type 2 diabetes who do not need insulin.

          Abbott is a key player in the market for continuous glucose monitors sold under prescription to diabetes patients, along with rivals DexCom DXCM.O and Medtronic MDT.N.

          FreeStyle Libre, Abbott's blood sugar monitor, generated $1.6 billion in sales globally in the second quarter. However, the company said the marketing for a consumer product would greatly differ from that for a medical device.

          "I don't think, given our experience here, that you can just go on TV, blast TV advertising and you'll get this big uptake. You are going to have to do some on-the-ground kind of guerilla marketing," Ford said during an analyst conference call.

          Guerilla marketing uses tactics such as on-ground outreach, social media campaigns, among others, and usually involve low budgets.

          Ford expects sales growth for Lingo to ramp up over time as the company builds the market.

          RBC Capital Markets analyst Shagun Singh does not currently model much in sales of Abbott and Dexcom's OTC products, but believes the market would be significant.

          Abbott is "literally just launching it this summer. So there will be a lot to learn for us, but substantial opportunities for both companies," said Singh.

          (Reporting by Leroy Leo and Puyaan Singh in Bengaluru; Editing by Shreya Biswas)

          (( Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7; ))

          Keywords: ABBOTT-GLUCOSE MONITORS/

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share
          FastBull
          Copyright © 2025 FastBull Ltd

          728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

          TelegramInstagramTwitterfacebooklinkedin
          App Store Google Play Google Play
          Products
          Charts

          Chats

          Q&A with Experts
          Screeners
          Economic Calendar
          Data
          Tools
          Membership
          Features
          Function
          Markets
          Copy Trading
          Latest Signals
          Contests
          News
          Analysis
          24/7
          Columns
          Education
          Company
          Careers
          About Us
          Contact Us
          Advertising
          Help Center
          Feedback
          User Agreement
          Privacy Policy
          Business

          White Label

          Data API

          Web Plug-ins

          Poster Maker

          Affiliate Program

          Risk Disclosure

          The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

          No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

          Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

          Not Logged In

          Log in to access more features

          FastBull Membership

          Not yet

          Purchase

          Become a signal provider
          Help Center
          Customer Service
          Dark Mode
          Price Up/Down Colors

          Log In

          Sign Up

          Position
          Layout
          Fullscreen
          Default to Chart
          The chart page opens by default when you visit fastbull.com